MedTech-2022 Conferences | MedTech -2022 | MedTech 2022 Events | Pharma Industry and MedTech | MedTech Conferences | MedTech Meetings | Pharma Industry and MedTech | | Pharma Industry and MedTech Congress
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology
Foresee Edebi sanatlar yelken achim aigner leipzig university germany Tren istasyonu ilgisiz yerine getirmek
Mitarbeiter des Rudolf-Boehm-Institutes
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology
Multiple effects of the special ATâ•'rich binding protein 1 (SATB1) in colon carcinoma
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology
Functional Role and Therapeutic Potential of the Pim-1 Kinase in Colon Carcinoma
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology
Module III – CAS in Radiopharmaceutical Chemistry/Radiopharmacy | ETH Zurich
Untersuchung der biologischen Aktivität von Nanopartikeln in Tumor- schnittkulturen
Targeted CRM197-PEG-PEI/siRNA Complexes for Therapeutic RNAi in Glioblastoma
Achim Aigner | Leipzig University, Germany | Pharmaceutica 2017 | Conferenceseries
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology
Loop | Achim Aigner
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology
C:/Users/julia/biotechnologische Studenteninitiative (btS) e.V/Leipzig - ScieGuide 2019/ScieGuide final 08.08/ScieGuide070819.sl
Mitarbeiter des Rudolf-Boehm-Institutes
Nanoparticle-complexed antimiRs for inhibiting tumor growth and metastasis in prostate carcinoma and melanoma
European Technology Platform on Nanomedicine
